Human Metabolome TechnologiesTSE:6090 +0.84%59 Median PS Value is 円905.64 as of Jul. 12, 2026, which is 100% below its 10-year median of 0.80. GuruFocus rates TSE:6090 with a GF Score™ of 59/100 and a GF Value™ of 円529.55 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 89 Medical Diagnostics & Research companies, Human Metabolome Technologies ranks better than 65.17% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Human Metabolome Technologies's Median PS Value or its related term are showing as below:
TSE:6090'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.45 Med: 0.8 Max: 1.03
Current: 0.66
During the past 12 years, the highest Price to Median PS Value of Human Metabolome Technologies was 1.03. The lowest was 0.45. And the median was 0.80.
TSE:6090's Price-to-Median-PS-Value is ranked better than 65.17% of 89
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.9
vs TSE:6090: 0.66
Human Metabolome Technologies (TSE:6090) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Human Metabolome Technologies's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
598.00
/
905.64
=
0.66
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Human Metabolome Technologies Median PS Value Related Terms
Human Metabolome Technologies Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Human Metabolome Technologies Median PS Value Chart
TSE:6090 vs TMO, DHR, IDXX: Median PS Value Comparison
For the Diagnostics & Research subindustry, Human Metabolome Technologies's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Human Metabolome Technologies Price-to-Median-PS-Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Human Metabolome Technologies's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Human Metabolome Technologies's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 6.2074.
Human Metabolome Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円145.896.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Human Metabolome Technologies (TSE:6090) has a Median PS Value of 円905.64 as of Jul. 12, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Human Metabolome Technologies and its competitors. This is 113105% above median its historical median of 0.80. Over the past decade, Human Metabolome Technologies' Median PS Value has ranged from 0.45 to 1.03. According to the industry distribution chart, Human Metabolome Technologies ranks #31 out of 89 companies in the Medical Diagnostics & Research industry, placing it in the top 34.8%.
Is Human Metabolome Technologies' Median PS Value too high?
Human Metabolome Technologies' current Median PS Value of 円905.64 is 113105% above median its 10-year median of 0.80. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 1.03. Based on the distribution chart, Human Metabolome Technologies ranks #31 out of 89 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Human Metabolome Technologies has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Human Metabolome Technologies' Median PS Value compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Human Metabolome Technologies ranks #31 out of 89 companies for Median PS Value. This puts Human Metabolome Technologies in the upper half of its industry. The industry median Median PS Value is 0.90. Historically, Human Metabolome Technologies' own Median PS Value has ranged from 0.45 to 1.03 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Diagnostics & Research company?
The median Median PS Value among Medical Diagnostics & Research companies is 0.90, based on 89 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Human Metabolome Technologies and its competitors. For the Medical Diagnostics & Research industry, the median Median PS Value is 0.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Human Metabolome Technologies's current Median PS Value is 円905.64, which is 113105% above median its own 10-year median of 0.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Metabolome Technologies stock overvalued right now?
Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Modestly Overvalued. The stock's GF Value™ is 円529.55, compared to a current price of 円598.00 — trading 12.9% above its estimated fair value. The current Median PS Value is 円905.64, which is 113105% above median its 10-year median of 0.80. Human Metabolome Technologies' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current Median PS Value is 円905.64 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?
Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be overvalued.
The current stock price of 円598.00 is trading 12.9% above its estimated GF Value™ of 円529.55.
GuruFocus considers Human Metabolome Technologies to be Modestly Overvalued.
Key valuation signals for TSE:6090:
Median PS Value: 円905.64 (113105% above median its 10-year median of 0.80)
GF Value™: 円529.55 vs. price of 円598.00 (12.9% above fair value)
No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Human Metabolome Technologies Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6090 has been successfully added to your 
